F883L

Category 3/4 — Most DruggableUncertain significanceLumenal · predictedσ-1 candidateSource card

Phenylalanine → Leucine at position 883 · C-terminal ER-lumenal (calcium binding, calmodulin, chaperone) · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference

Wild-type F883 — hydrogen bond to F886

Fullscreen ↗

DynaMut2 mutant · F883L

Mutant L883 — hydrogen bond to F879 lost (4 contacts lost)

Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

4 lost0 gained10 preserved

Interaction type	Wild-type partner	Mutant partner	Status
Hydrogen bond	F879	F879	Preserved
Hydrogen bond	D880	—	Lost
Hydrogen bond	F886	F886	Preserved
Hydrogen bond	L887	L887	Preserved
Polar contact	F879	F879	Preserved
Polar contact	D880	—	Lost
Polar contact	F886	F886	Preserved
Polar contact	L887	L887	Preserved
Aromatic / π	F879	—	Lost
Carbonyl	L887	L887	Preserved
Van der Waals	F879	—	Lost
Van der Waals	L887	L887	Preserved
Hydrophobic	F879	F879	Preserved
Hydrophobic	L887	L887	Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG

0.21kcal/mol

Stabilising — mild

AlphaMissense

0.815

likely pathogenic

AlphaFold pLDDT

model confidence

Schema

Cat 3/4

Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationUncertain significance

Review statuscriteria provided, single submitter

Associated conditions—

Population frequency (gnomAD v4)Absent from gnomAD v4

cDNA changec.2649C>G

ClinVar accessionVCV002864080

Last evaluated2023/05/30 00:00

Not observed in ~730k individuals — consistent with a rare allele (ACMG PM2_supporting).

Full Variant Card

WFS1 Wolframin — F883L Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Phenylalanine → Leucine at position 883. C-terminal ER-lumenal (calcium binding. ClinVar Uncertain significance, AlphaMissense 0.815, DynaMut2 ΔΔG +0.21 kcal/mol (stabilising).

Identity

Field	Value
Variant	F883L (p.Phenylalanine883Leucine)
DNA change	c.2649C>G
Gene · Protein	WFS1 · Wolframin (890 aa)
UniProt	O76024 · WFS1_HUMAN
ClinVar accession	VCV002864080
Amino acid change	Phenylalanine (F) → Leucine (L)

Structural Context

Field	Value
AlphaFold model	AF-O76024-F1, v6
pLDDT at residue 883	80.62 — well-folded
Domain	C-terminal ER-lumenal (calcium binding, calmodulin, chaperone)
Position context	C-terminal lumenal domain · position 883 projects into the ER lumen
IDR flag	No — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 883 sits in the C-terminal lumenal domain (residues 653–869), wolframin's largest soluble region. This domain projects into the ER lumen and is implicated in calcium handling, ER stress sensing, and protein–protein interactions with ATF6 and Na+/K+ ATPase β1. The wild-type residue is large aromatic hydrophobic (phenylalanine); the mutant is medium hydrophobic (leucine — branched). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.

Computational Predictions

AlphaMissense

Field	Value
am_pathogenicity	0.8154
am_class	likely pathogenic
Interpretation	Likely pathogenic (threshold 0.564)

DynaMut2

Field	Value
ΔΔG (kcal/mol)	0.21 (Stabilising)
Job ID	178092114925
Result URL	https://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092114925

Clinical Evidence

Field	Value
Classification	Uncertain significance
Review status	criteria provided, single submitter
Last evaluated	2023/05/30 00:00
Inheritance	Inheritance pattern not specified in ClinVar entry; WFS1 has both AD and AR presentations.
WFS1 variant landscape	F883L is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

(no conditions catalogued)

Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=0.21 < 2 kcal/mol (fold intact) + AlphaMissense 0.815 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=0.21 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.815. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.

Files in this folder

AF-O76024-F1-model_v6.pdb — AlphaFold structure
F883L_molstar_viewer.html — interactive 3D viewer (auto-highlights position 883 with ball-and-stick + neighbors within 5Å)
F883L_variant_card.md — this card (source of truth)
F883L_variant_card.html — styled printable card
F883L_dynamut2_summary.html — clean offline DynaMut2 result card
dynamut2_result.json — structured result data
dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
F883L_wildtype_interactions.pse / F883L_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the F883L PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download F883L PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.